1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Solid Tumors (Phase 1): new trials by email Literature Review of Solid Tumors (Phase 1) trials Research Report on Solid Tumors (Phase 1)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1/2 Study of USL311 +/- Lomustine in Advanced Solid Tumors or Relapsed/Recurrent Glioblastoma Multiforme (GBM) USL311, Lomustine - Solid Tumors (Phase 1), Relapsed/Recurrent GBM (Phase 2) | Phase 1 / Phase 2 | Terminated | Proximagen, LLC | 26 | 2016-04-01 | 2021-07-23 |
Brain Neoplasms (1) · Glioblastoma (1) · Neoplasms (1) · Recurrence (1)
Astrocytoma (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Disease Attributes (1) · Glioma (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1) · Neuroectodermal Tumors (1)
Lomustine (1)
Proximagen, LLC (1)
Spain (1) · United States (1)